Related Experiment Video
Updated: Feb 11, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
A Case of EBV-Driven Histiocytic Sarcoma as PTLD in a Pediatric Heart Transplant Patient
Kasey Chelemedos1, Nishma Shah2, Kaitlyn Quijano3
1Children's Hospital at Montefiore, Division of Pediatric Hematology/Oncology and Cellular Therapy.
Abstract:
Post-transplant lymphoproliferative disorders (PTLD) are typically EBV-driven neoplasms that occur after transplantation. Histiocytic sarcomas (HS) are rare malignancies. PTLD HS cases are even rarer. We discuss a case of multiorgan EBV+ HS PTLD in a pediatric male with a history of orthotopic heart transplant. He was initially treated broadly, then narrowed to disease-targeted therapy. Surveillance imaging showed improvement of his diffuse body lesions, but new leptomeningeal enhancements were identified. He developed neurological deterioration and succumbed to his disease. This is a rare case of PTLD manifesting as an EBV-driven HS with meningeal metastasis unresponsive to targeted therapy despite multiorgan improvement elsewhere.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Anatomy of the Heart

